Analysts Offer Insights on Healthcare Companies: Novadaq (NASDAQ: NVDQ) and Stryker (NYSE: SYK)

By Jason Carr

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novadaq (NASDAQ: NVDQ) and Stryker (NYSE: SYK) with bullish sentiments.

Novadaq (NASDAQ: NVDQ)

In a report released today, Jason Mills from Canaccord Genuity reiterated a Buy rating on Novadaq (NASDAQ: NVDQ), with a price target of $10. The company’s shares opened today at $11.70, close to its 52-week high of $12.74.

According to TipRanks.com, Mills is a 5-star analyst with an average return of 13.1% and a 68.3% success rate. Mills covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Trivascular Technologies, and Obalon Therapeutics Inc.

Novadaq has an analyst consensus of Moderate Buy, with a price target consensus of $11.39.

Stryker (NYSE: SYK)

In a report released today, Kyle Rose from Canaccord Genuity reiterated a Buy rating on Stryker (NYSE: SYK), with a price target of $146. The company’s shares opened today at $141.38, close to its 52-week high of $145.62.

According to TipRanks.com, Rose is a 4-star analyst with an average return of 6.6% and a 53.4% success rate. Rose covers the Healthcare sector, focusing on stocks such as Obalon Therapeutics Inc, Zimmer Biomet Holdings, and Zeltiq Aesthetics.

Currently, the analyst consensus on Stryker is Hold and the average price target is $141.09, representing a -0.2% downside.

In a report issued on June 13, Leerink Swann also maintained a Buy rating on the stock with a $158 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.